Investor Relations
Explore investment opportunities with Realigns Inc. — a global innovator in artificial intelligence, certified pharmaceuticals, and sustainable consumer brands. Through its strategic portfolio, Realigns Inc. provides scalable, multi-industry opportunities backed by compliance and credibility.
Company Overview
Realigns Inc. is a U.S.-registered C Corporation (Filing ID: 2022-001179737) incorporated in Wyoming with a registered capital of $10 million USD. The company operates internationally across the United States, Thailand, Pakistan, and Saudi Arabia with subsidiaries and brand assets in AI, e-commerce, organic beauty manufacturing, and premium fashion.
Realigns Pharmaceuticals Co., Ltd., a Thailand-registered subsidiary with paid-up capital of 4 million Thai Baht, is a certified OEM manufacturer under GMP, Thai FDA, and ISO 22716 standards. It supports global exports and private label production for beauty and skincare products.
Valuation Summary (2025)
| Metric | Value |
|---|---|
| Enterprise Valuation (DCF-Based) | $9.64 million USD |
| Registered Capital (Realigns Inc.) | $10,000,000 USD |
| Registered Capital (Realigns Pharmaceuticals Co., Ltd.) | 4 million THB |
| Total Authorized Shares (Realigns Inc.) | 10,000,000 shares |
| Shares Issued | 7,000,000 shares |
| Pre-Share Valuation | $1.00 per share |
| Target EBITDA Margin | 25% |
| State Filing Compliance | Good Standing (Wyoming) – Next Due: 2025 |
EBITDA Margin Justification
The projected EBITDA margin of 25% is based on a blended, conservative estimate derived from:
- AI Media & SaaS: 40–60% EBITDA margin
- Amazon Private Label & Services: 15–30%
- Certified Cosmetic OEM Manufacturing: 10–25%
Weighted average: ~29.5%, adjusted to 25% to support realistic valuation modeling and risk control.
Revenue Highlights
Dellameria Pink Lips Smokers Cream, the flagship product under Realigns Pharmaceuticals Co., Ltd. (Thailand), has surpassed $1 million USD in global sales. Actively distributed in 24+ countries including the UAE, Pakistan, Saudi Arabia, and Canada, the product showcases our capability in branding, export operations, and regulatory adherence worldwide.
Equity Structure (Realigns Inc.)
| Shareholder Type | Shares Held | % Ownership |
|---|---|---|
| Founder & Leadership | 6,000,000 | 60% |
| Strategic Advisors & Team | 1,000,000 | 10% |
| ESOP Reserve | 1,000,000 | 10% |
| Future Investors | 2,000,000 | 20% (Open for Investment) |
Note: Shares are issued as common stock unless otherwise specified. Certificates and equity transfers are governed by board oversight and digital issuance standards.
Our Brand Portfolio
| Brand / Subsidiary | Focus Area | Website |
|---|---|---|
| InlinkTech | AI Software, GPT Integration, ERP, Cybersecurity | inlinktech.com |
| Dellameria | Organic Skincare, Personal Care, OEM Cosmetics | dellameria.com |
| Edwin Luka | Luxury Fashion & Sustainable Lifestyle (Coming Soon) | edwinluka.com |
| Realigns Pharmaceuticals Co., Ltd. | Thai-based Certified OEM Manufacturer | realignsinc.com |
Investment Highlights
- ✅ C Corporation registered and compliant in the United States
- Active global presence in USA, Thailand, Pakistan, and KSA
- Revenue-generating brand with $1M+ international product sales
- Certified pharmaceutical manufacturing capabilities in Thailand
- Proprietary AI tools and export-ready product IP
- Harvard-certified founder with 20+ years global experience
Downloadable Investor Documents
Contact Investor Relations
Email: support@realignsinc.com
Website: www.realignsinc.com
Schedule a Meeting